Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Ebako Ndip Takem, Christopher Coox, Judith Shang, Clement Ndongmo, Emily Kainne Dokubo
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study
10.1097/01.aids.0000433239.01611.52 · 2014
Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation
10.1097/qad.0000000000000082 · 2014
Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya
10.1097/qai.0000000000000312 · 2014
Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial
10.1016/s2352-3018(19)30337-6 · 2020
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study
10.1016/s1473-3099(11)70255-9 · 2012
Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya
10.1371/journal.pone.0210559 · 2019
Does Tenofovir-containing First-line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-nucleoside Reverse Transcriptase Inhibitor Drug Resistance?
10.1093/cid/ciy1070 · 2019
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
10.1097/qad.0000000000002588 · 2020
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial
10.1093/cid/civ102 · 2015
Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
10.1093/jac/dkx188 · 2017
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda
10.1089/aid.2014.0043 · 2014
Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women
10.1097/qad.0000000000002134 · 2019
HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment
10.1097/qad.0000000000003182 · 2022
The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study
10.1186/s12879-020-4933-z · 2020
Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa. Clinical infectious diseases: an official publication of the
10.1093/cid/civ656 · 2015
Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-naïve Ugandan children
10.1111/apa.15320 · 2020
Pretreatment HIV drug resistance among adults initiating ART in Namibia
10.1093/jac/dky278 · 2018
Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort Study
10.3390/pathogens8040161 · 2019
Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005–2013
10.1089/apc.2018.0020 · 2018
Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi
10.1186/s12981-020-00282-3 · 2020
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali
10.1097/inf.0000000000001575 · 2017
Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals
10.1093/jac/dkaa343 · 2020
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
10.1038/s41467-020-19801-x · 2020
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
10.1097/qad.0b013e3283492180 · 2011
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021
Unresolved referenced work
1878
High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children
10.7448/ias.19.1.21140 · 2016
Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia
10.1097/qai.0000000000000509 · 2015
Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children
10.1093/cid/ciq161 · 2011
Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008–2010
10.1186/s13104-016-2101-8 · 2016
Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?
10.1186/s12985-016-0628-x · 2016
Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda
10.1089/aid.2011.0352 · 2012
Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing
10.1038/s41598-018-25888-6 · 2018
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda
10.1089/aid.2009.0164 · 2010
High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study
10.1097/qai.0000000000003027 · 2022
Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.
10.1093/cid/ciaa1161 · 2021
Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis
10.1097/qad.0000000000000261 · 2014
Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana
10.1097/qad.0000000000003041 · 2021
Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis
10.1093/jac/dkw463 · doi-reference
High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa
10.1097/qad.0000000000002580 · doi-reference
Assessment of selection bias due to dropouts in the follow-up of the Scania Public Health Cohort
10.1177/1403494820919544 · doi-reference
A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa
10.1093/aje/kwr444 · doi-reference